TY - JOUR
T1 - Activation of NF-κB by bradykinin through a Gα(q)- and Gβγ-dependent pathway that involves phosphoinositide 3-kinase and Akt
AU - Xie, P.
AU - Browning, D. D.
AU - Hay, N.
AU - Mackman, N.
AU - Ye, R. D.
PY - 2000/8/11
Y1 - 2000/8/11
N2 - Recent work has suggested a role for the serine/threonine kinase Akt and IκB kinases (IKKs) in nuclear factor (NF)-κB activation. In this study, the involvement of these components in NF-κB activation through a G protein-coupled pathway was examined using transfected HeLa cells that express the B2-type bradykinin (BK) receptor. The function of IKK2, and to a lesser extent, IKK1, was suggested by BK-induced activation of their kinase activities and by the ability of their dominant negative mutants to inhibit BK-induced NF-κB activation. BK-induced NF-κB activation and IKK2 activity were markedly inhibited by RGS3T, a regulator of G protein signaling that inhibits Gα(q), and by two Gβγ scavengers. Co-expression of Gα(q) potentiated BK-induced NF-κB activation, whereas co-expression of either an activated Gα(q)(Q209L) or Gβ1γ2 induced IKK2 activity and NF-κB activation without BK stimulation. BK-induced NF-κB activation was partially blocked by LY294002 and by a dominant negative mutant of phosphoinositide 3-kinase (PI3K), suggesting that PI3K is a downstream effector of Gα(q) and Gβ1γ2 for NF-κB activation. Furthermore, BK could activate the PI3K downstream kinase Akt, whereas a catalytically inactive mutant of Akt inhibited BK-induced NF-κB activation. Taken together, these findings suggest that BK utilizes a signaling pathway that involves Gα(q), Gβ1γ2, PI3K, Akt, and IKK for NF-κB activation.
AB - Recent work has suggested a role for the serine/threonine kinase Akt and IκB kinases (IKKs) in nuclear factor (NF)-κB activation. In this study, the involvement of these components in NF-κB activation through a G protein-coupled pathway was examined using transfected HeLa cells that express the B2-type bradykinin (BK) receptor. The function of IKK2, and to a lesser extent, IKK1, was suggested by BK-induced activation of their kinase activities and by the ability of their dominant negative mutants to inhibit BK-induced NF-κB activation. BK-induced NF-κB activation and IKK2 activity were markedly inhibited by RGS3T, a regulator of G protein signaling that inhibits Gα(q), and by two Gβγ scavengers. Co-expression of Gα(q) potentiated BK-induced NF-κB activation, whereas co-expression of either an activated Gα(q)(Q209L) or Gβ1γ2 induced IKK2 activity and NF-κB activation without BK stimulation. BK-induced NF-κB activation was partially blocked by LY294002 and by a dominant negative mutant of phosphoinositide 3-kinase (PI3K), suggesting that PI3K is a downstream effector of Gα(q) and Gβ1γ2 for NF-κB activation. Furthermore, BK could activate the PI3K downstream kinase Akt, whereas a catalytically inactive mutant of Akt inhibited BK-induced NF-κB activation. Taken together, these findings suggest that BK utilizes a signaling pathway that involves Gα(q), Gβ1γ2, PI3K, Akt, and IKK for NF-κB activation.
UR - http://www.scopus.com/inward/record.url?scp=0034637556&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034637556&partnerID=8YFLogxK
U2 - 10.1074/jbc.M001051200
DO - 10.1074/jbc.M001051200
M3 - Article
C2 - 10801799
AN - SCOPUS:0034637556
SN - 0021-9258
VL - 275
SP - 24907
EP - 24914
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 32
ER -